[iframe https://s.tradingview.com/embed-widget/symbol-info/?locale=in&symbol=ADAG#%7B%22symbol%22%3A%22A%22%2C%22width%22%3A%22100%25%22%2C%22colorTheme%22%3A%22light%22%2C%22isTransparent%22%3Atrue%2C%22height%22%3A203%2C%22utm_source%22%3A%22themarketstracker.com%22%2C%22utm_medium%22%3A%22widget_new%22%2C%22utm_campaign%22%3A%22symbol-info%22%7D 900 250 ]

ADAG — Price & Float Short

—— Fair value ★ EPS beat ★ EPS miss —— Target Price

Float Short %

1.93

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

-0.21

EPS This/Next Y

-0.01

Price

3.43

Target Price

9.4

Analyst Recom

1.33

Performance Q

16.04

Upside

-241.5%

Beta

0.64

Ticker: ADAG

20 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-05-11	ADAG	3.75	N/A	N/A	0
2026-05-12	ADAG	3.7	N/A	N/A	0
2026-05-13	ADAG	3.67	N/A	N/A	0
2026-05-14	ADAG	3.65	N/A	N/A	0
2026-05-15	ADAG	3.49	N/A	N/A	0
2026-05-18	ADAG	3.43	N/A	N/A	0
2026-05-19	ADAG	3.4	N/A	N/A	0
2026-05-20	ADAG	3.42	N/A	N/A	0
2026-05-21	ADAG	3.82	N/A	N/A	0
2026-05-22	ADAG	3.74	N/A	N/A	0
2026-05-26	ADAG	3.72	N/A	N/A	0
2026-05-27	ADAG	4	N/A	N/A	0
2026-05-28	ADAG	4	N/A	N/A	0
2026-05-29	ADAG	4	N/A	N/A	0
2026-06-02	ADAG	3.38	N/A	N/A	0
2026-06-03	ADAG	3.46	N/A	N/A	0
2026-06-04	ADAG	3.52	N/A	N/A	0
2026-06-05	ADAG	3.36	N/A	N/A	0
2026-06-08	ADAG	3.27	N/A	N/A	0
2026-06-09	ADAG	3.46	N/A	N/A	0
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

20 items 1 of 1

21 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2026-05-11	ADAG	3.76	-	-	-0.51
2026-05-12	ADAG	3.70	-	-	-0.51
2026-05-13	ADAG	3.67	-	-	-0.51
2026-05-14	ADAG	3.63	-	-	-0.51
2026-05-15	ADAG	3.54	-	-	-0.51
2026-05-18	ADAG	3.44	-	-	-0.51
2026-05-19	ADAG	3.42	-	-	-0.51
2026-05-20	ADAG	3.43	-	-	-0.51
2026-05-21	ADAG	3.81	-	-	-0.51
2026-05-22	ADAG	3.75	-	-	-0.51
2026-05-26	ADAG	3.71	-	-	-0.51
2026-05-27	ADAG	4.01	-	-	-0.51
2026-05-28	ADAG	3.97	-	-	-0.51
2026-05-29	ADAG	3.97	-	-	-0.51
2026-06-01	ADAG	3.82	-	-	-0.51
2026-06-02	ADAG	3.43	-	-	-0.51
2026-06-03	ADAG	3.42	-	-	-0.51
2026-06-04	ADAG	3.56	-	-	-0.51
2026-06-05	ADAG	3.34	-	-	-0.51
2026-06-08	ADAG	3.25	-	-	-0.51
2026-06-09	ADAG	3.43	-	-	-0.51
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

21 items 1 of 1

20 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2026-05-11	ADAG	0.00	-6.90	1.04
2026-05-12	ADAG	0.00	-6.90	1.67
2026-05-13	ADAG	0.00	-6.90	1.67
2026-05-14	ADAG	0.00	-6.90	1.59
2026-05-15	ADAG	0.00	-6.90	1.59
2026-05-18	ADAG	0.00	10.12	1.59
2026-05-19	ADAG	0.00	10.12	1.59
2026-05-20	ADAG	0.00	10.12	1.59
2026-05-21	ADAG	0.00	10.12	1.59
2026-05-22	ADAG	0.00	10.12	1.59
2026-05-26	ADAG	0.00	16.93	1.59
2026-05-27	ADAG	0.00	16.93	1.59
2026-05-28	ADAG	0.00	16.93	1.93
2026-05-29	ADAG	0.00	16.93	1.93
2026-06-02	ADAG	0.00	16.93	1.93
2026-06-03	ADAG	0.00	16.93	1.93
2026-06-04	ADAG	0.00	16.93	1.93
2026-06-05	ADAG	0.00	16.93	1.93
2026-06-08	ADAG	0.00	16.93	1.93
2026-06-09	ADAG	0.00	16.93	1.93
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

20 items 1 of 1

[iframe https://widget.finnhub.io/widgets/historical-eps?symbol=ADAG 589 360 ]

Last Quarter Act. EPS

Avg. EPS Est. Current Quarter

-0.15

Avg. EPS Est. Next Quarter

-0.19

Insider Transactions

Institutional Transactions

16.93

Beta

0.64

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

83.7

Max Drawdown 5-Year %

-95.6

Target Price

9.4

P/E

Forward P/E

PEG

P/S

20.95

P/B

4.56

P/Free Cash Flow

EPS

-0.37

Average EPS Est. Cur. Y

-0.51

EPS Next Y. (Est.)

-0.52

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-229.49

Relative Volume

0.4

Return on Equity vs Sector %

-77.3

Return on Equity vs Industry %

-61.1

EPS 1 7Days Diff

0.2

EPS 1 30Days Diff

0.21

EBIT Estimation

[iframe https://widget.finnhub.io/widgets/recommendation?symbol=ADAG 589 450 ]

[iframe https://widget.finnhub.io/widgets/eps-estimate?symbol=ADAG 589 450 ]

◆ ADAG Healthcare

$3.40

📉

Swing / Pullback

Buy the dip on strong trends

N/A

WEAK

Trend

6/20

Pullback

21/25

Volume

11/15

Valuation

10/20

TP/AR

4/10

Options

0/10

RSI

43.9

Range 1M

25.6%

Sup Dist

6.2%

🚀

Momentum Growth

Ride accelerating trends

N/A

WEAK

Momentum

3/25

Growth

5/30

Estimates

2/20

Inst/Vol

8/15

Options

0/10

EPS Yr

-61.7%

EPS NY

-3.1%

52W%

61.7%

💎

Long-Term Value

Quality companies, undervalued

N/A

WEAK

🟢 BUY +176.5% upside

Quality

6/30

Valuation

16/30

Growth

2/25

Stability

7/10

LT Trend

3/5

Upside

+176.5%

Quality

Adagene Inc.

Sector: Healthcare

Industry: Biotechnology

Employees: 128

Adagene Inc., a clinical stage biotechnology company, engages in the research, development, and production of monoclonal antibody drugs for cancers in the People's Republic of China. Its lead product candidate is the ADG126, a masked fully-human anti-CTLA-4 mAb which is in phase 1b/2 clinical development for the treatment of cancer. The company also develops ADG116, a fully human anti-CTLA-4 antibody generated using NEObody technology, which is in phase 1b/2 clinical trials to treat advanced/metastatic solid tumors; ADG206, which is in phase 1 clinical development to treat advanced metastatic solid tumors; ADG104, anti-PD-L1 monoclonal antibody which is in phase 2 clinical development; and ADG125, a novel anti-CSF-1R mAb which is in Phase 2 clinical development. In addition, it is developing ADG138, a HER2xCD3 POWERbody which is in pre clinical trial to treat low expressing tumors, as well as resistant/refractory tumors; ADG152, a CD20xCD3 POWERbody which is in preclincal trial to treat off-tumor toxicities; ADG153, a masked anti-CD47 IgG1 SAFEbody, wihx is in preclinical trial for the treatment of hematologic and solid tumor; and CD28 T-cell engagers, an anti-CD28 bispecific POWERbody TCEs to treat solid tumors. Adagene Inc. was incorporated in 2011 and is headquartered in Suzhou, China.

ADAG

Latest News

—

Caricamento notizie per ADAG…

stock quote shares ADAG – Adagene Inc. Stock Price stock today

news today ADAG – Adagene Inc. stock forecast ,stock prediction 2023 2024 2025

marketwatch ADAG – Adagene Inc. yahoo finance google finance

stock history ADAG – Adagene Inc. invest stock market

stock prices ADAG premarket after hours

ticker ADAG fair value insiders trading

ADAG – Adagene Inc.

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Upside

Beta

Ticker: ADAG

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Latest News

Last Quarter Act. EPS

Average EPS Est. Cur. Y